human paramyxovirus include global caps lower respiratory disease like parainfluenza virus well agent lethal except ninth virus infect init viral glycoproteinmedi fusion host cell membrane paramyxoviru protein f insert target membrane form transient intermedia pull together two heptadrepeat region resold sixhelix bundle structure specify target fusioninhibitori peptide antivirus potent improv sequence modify lipid concur ad linked protein common exploit unique broad spectrum active derive peptide inhibit investing influence orient intervene linked length interact transit state soluble insert kinen proteam density ass impact feature biodistribut efficacy vitro vivo engine approach base biopsy parapet result highly effect inhibitor set criterion use antivirus emerge 